Phytogen Life Sciences

Phytogen Life Sciences is a biotechnology company specializing in the development and manufacture of high-purity plant-derived active pharmaceutical ingredients (APIs). The company is a global leader in the production of taxanes, including paclitaxel and docetaxel, which are critical components in various chemotherapy regimens for treating breast, ovarian, and lung cancers. Based in British Columbia, Canada, Phytogen utilizes advanced extraction and semi-synthetic purification technologies to supply the global pharmaceutical industry. Since its acquisition by the Italian botanical firm Indena S.p.A., the company has integrated its operations into a broader portfolio of botanical derivatives and medicinal compounds. Phytogen's expertise lies in bridging the gap between complex natural sources and the rigorous quality standards required for modern oncology therapeutics.